Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$755
|
$714B |
12.6x |
29.7x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$178
|
$461B |
5.0x |
13.7x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$218
|
$450B |
7.6x |
16.5x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$83
|
$234B |
3.6x |
8.1x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$276
|
$197B |
5.6x |
10.7x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$24
|
$183B |
2.9x |
7.4x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$115
|
$162B |
5.6x |
11.2x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$46
|
$131B |
2.8x |
8.8x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$395
|
$96.3B |
8.2x |
23.7x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$148
|
$71.0B |
7.5x |
17.3x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$25.6B |
1.8x |
6.0x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$145
|
$25.1B |
2.6x |
7.7x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$36
|
$22.2B |
7.5x |
8.1x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$142
|
$13.5B |
5.1x |
21.4x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$11.1B |
1.8x |
5.7x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$77
|
$10.0B |
8.1x |
12.4x |
Verona Pharma
|
United States of America |
Biopharmaceuticals
|
$106
|
$9.0B |
28.8x |
-534.2x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$5.7B |
1.9x |
8.5x |
ADMA Biologics
|
United States of America |
Biopharmaceuticals
|
$16
|
$3.8B |
8.0x |
18.2x |
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$41
|
$3.8B |
38.8x |
-41.1x |
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$3.6B |
5.9x |
17.1x |
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$27
|
$3.5B |
2.4x |
9.3x |
Procaps Group
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$1
|
$3.2B |
N/A |
N/A |
Metsera
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$36
|
$3.2B |
N/A |
N/A |
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$32
|
$2.8B |
689.1x |
-8.4x |
Mineralys Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$37
|
$2.6B |
N/A |
-13.2x |
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$98
|
$2.5B |
3.3x |
12.7x |
Kiniksa Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$37
|
$2.5B |
4.3x |
43.7x |
Celcuity
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$55
|
$2.3B |
N/A |
-15.3x |
Travere Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$23
|
$2.2B |
6.0x |
-19.8x |
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$69
|
$2.1B |
N/A |
N/A |
Supernus Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$45
|
$2.1B |
3.0x |
11.9x |
Arcutis Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$17
|
$2.0B |
6.8x |
-31.8x |
NewAmsterdam Pharma Co
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$24
|
$2.0B |
55.4x |
N/A |
Collegium Pharmaceutical
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$37
|
$1.8B |
2.5x |
4.1x |
Tarsus Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$49
|
$1.8B |
5.0x |
-26.8x |
Amphastar Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$28
|
$1.7B |
2.4x |
6.4x |
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$1.7B |
N/A |
-8.2x |
Harrow
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$39
|
$1.6B |
6.4x |
26.1x |
Ardelyx
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$7
|
$1.6B |
4.2x |
-107.5x |
Disc Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$60
|
$1.5B |
N/A |
-7.7x |
Aurinia Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$1.4B |
5.6x |
N/A |
Avadel Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$15
|
$1.4B |
5.9x |
65.9x |
Xeris Biopharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$1.4B |
5.4x |
41.8x |
Pharvaris
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$23
|
$1.3B |
N/A |
-6.9x |
OPKO Health
|
United States of America |
Biopharmaceuticals,
Medical Imaging & Diagnostics
|
$1
|
$1.2B |
1.9x |
-9.1x |
Dianthus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$37
|
$1.2B |
337.4x |
N/A |
Innoviva
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$19
|
$1.2B |
3.1x |
N/A |
Stoke Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$23
|
$1.0B |
7.4x |
-46.1x |
Tourmaline Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$48
|
$984M |
187.1x |
N/A |
Nika Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
$1
|
$983M |
N/A |
N/A |
LENZ Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$41
|
$970M |
107.3x |
-13.5x |
Zymeworks
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$16
|
$929M |
8.0x |
-14.4x |
WAVE Life Sciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$7
|
$923M |
13.8x |
-5.5x |
Phathom Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$12
|
$896M |
6.6x |
-5.0x |
Syndax
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$16
|
$872M |
6.8x |
-3.0x |
Rapport Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$24
|
$847M |
N/A |
-7.4x |
Sana Biotechnology
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$3
|
$841M |
N/A |
-3.9x |
Emergent BioSolutions
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$8
|
$835M |
1.0x |
4.6x |
UroGen Pharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$19
|
$798M |
7.0x |
-7.2x |
Spyre Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$16
|
$791M |
11455.1x |
-3.7x |
Esperion Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$3
|
$789M |
2.2x |
29.2x |
Maze Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Digital Therapeutics
|
$23
|
$782M |
15.6x |
-9.0x |
Dynavax
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$9
|
$775M |
2.4x |
39.6x |
ORIC Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$11
|
$768M |
N/A |
-5.3x |
Arbutus Biopharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$4
|
$758M |
63.5x |
N/A |
Sionna Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$23
|
$754M |
N/A |
-9.2x |
Elite Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1
|
$734M |
N/A |
N/A |
Ironwood Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1
|
$719M |
2.4x |
6.3x |
Oculis Holding
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$17
|
$711M |
736.7x |
-7.8x |
Anavex Life Sciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$704M |
N/A |
N/A |
Akebia Therapeutics
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$3
|
$698M |
3.4x |
N/A |
Enliven Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$20
|
$692M |
138213.2x |
-5.9x |
89bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$673M |
N/A |
-1.9x |
Tango Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$7
|
$581M |
10.7x |
N/A |
Zenas BioPharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$20
|
$580M |
22.3x |
-3.1x |
Mind Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$576M |
N/A |
-4.2x |
ArriVent BioPharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$20
|
$564M |
N/A |
-4.4x |
Upstream Bio
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$18
|
$555M |
214.6x |
-4.1x |
Nuvation Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$3
|
$525M |
21.5x |
N/A |
Savara
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$4
|
$499M |
N/A |
N/A |
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$38
|
$493M |
171.8x |
-1.9x |
SIGA Technologies
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$9
|
$457M |
4.0x |
8.9x |
Arcus Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$12
|
$424M |
1.7x |
-1.2x |
Tyra Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$13
|
$377M |
N/A |
-3.1x |
CytoDyn
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$0
|
$373M |
N/A |
N/A |
Lexicon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$1
|
$336M |
9.1x |
-3.0x |
Septerna
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Small Molecules
|
$14
|
$335M |
5.5x |
-4.9x |
Y-mAbs Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$331M |
4.0x |
-8.5x |
Terns Pharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$7
|
$318M |
N/A |
-2.9x |
Arcturus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$17
|
$301M |
2.8x |
-4.1x |
Day One Biopharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$7
|
$279M |
2.0x |
-1.7x |
Astria Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$7
|
$260M |
27.1x |
-1.8x |
Armata Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$3
|
$246M |
45.6x |
-6.6x |
Alpha Teknova
|
United States of America |
Contract Research & Manufacturing,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$4
|
$243M |
6.1x |
-23.3x |
Mereo BioPharma Group
|
United States of America |
Biopharmaceuticals
|
$2
|
$239M |
12.7x |
-10.9x |
Xencor
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$237M |
1.8x |
-1.3x |
Aura Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$6
|
$225M |
N/A |
N/A |
Regenxbio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$9
|
$219M |
1.2x |
-2.1x |
OmniAb
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$2
|
$216M |
9.3x |
-5.3x |